55 stories tagged with #glp, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Glp"
Chinese drug manufacturer with CCP ties imported unauthorized GLP-1 drug ingredients
Federal investigators say that a Chinese drug manufacturer, previously on the Food and Drug Administration’s list of preapproved foreign companies allowed to import GLP-1 ingredien…
GLP-1 and women, the AI office boom, and RTO: CEO ego?
It’s Indicators of the Week (now on YouTube!).On today’s episode: The effect of GLP-1s on women and the workplace; NYC’s once flailing office space is BACK; your boss asking you to…
Are GLP-1s Performance-Enhancing Drugs?
A weight-loss medication eased Serena Williams’s comeback. Experts can’t agree on whether that’s doping.…
GLP-1s drugs like Ozempic may actually boost fertility in men: study
Obesity is associated with both low testosterone and poor sperm quality. Researchers believe that it's the weight loss that brings the unintended, but welcome, fertility benefits.…
New drug could fight ‘Ozempic butt’ — and some other unwelcome side effects of GLP-1 drugs
You may yet be able to lean out without losing out as a new drug promises to save GLP-1 users from the flat fate of "Ozempic butt."…
People are battling ‘ghost fat’ after losing weight on GLP-1s
Sometimes, seeing isn't believing.…
Mayim Bialik details ‘explosive’ side effects of ‘nightmare’ GLP-1 drug
The "Blossom" alum wrote that "to say I had an adverse reaction would be somewhat of an understatement."…
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.…
Factor Promo Code: 50% Off Off Meal Prep
Make meal prep easier for any dietary need while enjoying great savings with our hand-picked Factor discount codes this June.…
Bernstein cuts food giants as GLP-1s, health trends threaten growth outlooks
Doctor explains study showing GLP-1s may lower breast cancer risk
A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.…
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fig…
GLP-1 drugs may have a beneficial effect across many types of cancer
June 3 - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. Read more at s…
Gestational GLP-1s Tied to Adverse Obstetric Outcomes
Underlying diabetes and discontinuation rebound in mothers with overweight are likely responsible rather than the drug itself.…
Name tweak could boost GLP-1 access for one in eight women suffering PMOS
Millions of women could soon have greater access to GLP-1 weight loss medications following the global effort to change the name of a hormonal condition that affects 1 in 8 women g…
ELI5: glp-1 vs Ozempic, what is the difference?
Can Ozempic Treat Alcoholism? Here’s What You Should Know
A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.…
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.…
Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.…
Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
GLP-1s and the Limits of Knowing Better
GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers.…
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.
Everyone’s on GLP-1s. But at What Cost?
As compounded versions proliferate, reports of eating disorders and adolescent use are on the rise.…
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.…
The weirdest GLP-1 side effect yet? The bizarre way weight loss drugs are messing with people’s hearing
“You’re in your own head, hearing yourself like Darth Vader,” Sarah Ago, a GLP-1 user, told The Post.…
Can GLP-1 drugs save the mall?
Vote now for the Longlpex Baseball MVPs in each division
Who was the most valuable player in each of the RIIL's three divisions this regular season? Cast your votes now!…
The Next Frontier For GLP-1 Medications: Potential Therapy For Inflammation
According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.…
GLP-1s take bite out of stomach weight-loss surgeries: Research
Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered
GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.…
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Do GLP-1 Medications Pay for Themselves?
Controversial liquid touted by biohackers may help hair grow — and prevent thinning caused by GLP-1s
Balding might make you blue — but this news won’t.…
GLP-1s Tied to Weight Loss in Real-World Rheumatologic Care
Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users…
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis was less likely to progress to stage 4.…
Eli Lilly (LLY) Sees Strong Growth Driven by Mounjaro Momentum and GLP-1 Demand, Barclays Remains Bullish
‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.…
GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade)
GoodRx stock is upgraded to "Neutral" after Q1 earnings. Here's what investors need to know.…
CUZ vs. GLPI: Which Stock Is the Better Value Option?
Are Investors Undervaluing Global Partners (GLP) Right Now?
HQH: GLP-1 Market Growth Offers Upside But Portfolio Structure A Bit Inefficient
abrdn Healthcare Investors (HQH) offers high-yield healthcare exposure, but a tight NAV discount and payout risks warrant caution—read the hold thesis now.…
“People still want to indulge” – Toms Group CEO Annette Zeipel surveys GLP-1 wave as confectionery grapples with cocoa volatility
Novo Nordisk: 2 Reasons To Buy This GLP-1 Giant
Novo Nordisk's pipeline positions it closer to Eli Lilly than market sentiment suggests. Click here to see why NVO stock is a Buy.…
Cardiorenal Benefits of GLP-1s Found in Type 1 Diabetes
A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.…
HQL: Attractive Outlook With Growth Of GLP-1 Market
Discover why HQL earns a buy rating: 12.6% yield, 8.49% NAV discount, GLP-1 biotech upside, plus key risks for income investors—read now.…
French Regulators Fine Novo, Lilly Over GLP-1 Campaigns
French regulators say obesity awareness campaigns may blur the line between public education and the promotion of prescription weight-loss drugs.…
GLP-1s Curb Hunger; Snacks Keep Blood Sugar Stable
If three meals a day is too much, patients can turn to healthy snacks.…
A Practical Guide to Make Digital Tools Work With GLP-1s
The learning curve can be steep for patients trying apps, wearables, and telehealth platforms. Your expertise is needed.…
Why GLP-1s aren't lowering employers' costs
The vast majority of employer health plans do not cover GLP-1s for weight loss. But roughly 20% do, many believing it will help their bottom line. Perhaps when employees take Wegov…
Some people lose far more weight than others on GLP-1s like Wegovy. Here’s why.
Hims & Hers Health: GLP-1 Drama Ending Signals Return To Growth
Hims & Hers Health rebounds post-GLP-1 shift; 2026 revenue target $3B and Eucalyptus upside.…
Experimental weight-loss drug outperforms original GLP-1s
An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a study published in Nature.…